The US is the largest single national market for prescription drugs, and spending levels on drugs and consumption levels are important barometers for the financial health of the pharmaceutical market. A recent report, , by the IMS Institute for Healthcare Informatics shows slowing sp...
Drug store/pharmacy market in the U.S. - Get the report with graphs and tables on statista.com!
What was the market size of the Pharmacies & Drug Stores industry in the US in 2024? The market size, measured by revenue, of the Pharmacies & Drug Stores industry was $629.7bn in 2024. What was the growth rate of the Pharmacies & Drug Stores industry in the US in 2024? The market ...
Drug, and Cosmetics Act designates the USP-NF as the official compendia for drugs marketed in the United States. A drug product in the U.S. market must conform to the standards in USP-NF to avoid possible charges of adulteration and misbranding. The USP-NF is also widely used by manufac...
2023 & 2024 United States Over-The-Counter Drugs market size report includes a forecast to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
Drug development is costly so drug makers need accurate estimates of sales potential. However, sales forecasts are often unreliable. Our study is unique in combRegnier, StephaneRidley, David B.Social Science Electronic PublishingRegnier, St. A., D. B. Ridley, 2015: Forecasting Market Share in ...
In England, France, and Switzerland, the drug’s therapeutic value is generally assessed after approval and serves as a basis for the drug’s launch price. In Germany, the therapeutic value is assessed during the drug’s first year on the market. For example, value reassessment occurs also ...
The US market is not as promising in terms of growth as it once was due to the maturity of the market.Competition is very strong,which poses only one of several obstacles for new investors. But it contains many potential consumers and a considerable number of them are willing to pay signif...
, Enbrel and Remicade—all face biosimilar competition in Europe. Only Remicade has competition from a lower-cost biosimilar in the U.S., and Humira isn't expected to have a copycat competitor in the U.S. market until 2023. Humira, made by AbbVie, is the world's top-selling drug....
In recent years, biotech has claimed an increasing share of novel treatments approved by the US Food and Drug Administration; that trend will shift this year. Although recombinant drugs account for more than one-third of candidates in discovery, the share dwindles along the pipeline. Currently, ...